News

Fralin Biomedical Research Institute officially opens $90 million addition

State and local officials gathered for the grand opening of the newest building at the Fralin Biomedical Research Institute in Roanoke.

The COVID-19 pandemic delayed the ribbon-cutting ceremony for the 139,000-square-foot addition, which opened to researchers and staff last summer. The building, located at 4 Riverside Circle on the Virginia Tech Carilion Health Sciences campus, will accommodate at least 400 more researchers, students and staff.

“Today was worth the wait,” Carilion CEO Nancy Agee said. “We’re putting Roanoke on the map for biosciences.”

The $90-million building houses advanced MRI and CT imaging machines, 3D printers, and microscopes that can see down to the nanometer. One researcher said the microscope he uses for his research costs as much as two Lamborghinis — about $750,000.

Researchers are using this technology to study brain formation, cancer cells, heart disease and memory.

The facility is also home to Virginia Tech’s molecular diagnostics lab, which has processed more than 160,000 COVID-19 tests since April 2020. The facility also holds the Virginia Tech Animal Cancer Care and Research Center to provide medical, surgical and radiation oncology treatments to cats and dogs.

Rachana Somaiya, a graduate student at the institute, said she has been studying how circuits in the brain form and how that could connect to solutions for brain-centered diseases. She said her parents, who live in India, never got the opportunity to attend college and she is grateful to be able to study at the institute and in its newest facility.

“I feel thankful to be a scientist studying the stunning complexity of the brain,” Somaiya said.

“It’s because this institute gave me a chance for quality education and more importantly, a welcoming environment to conduct extraordinary scientific research.”

Learn more here.

Recent News

04/24/2026

Skyphos Technologies Has Been Awarded its Second U.S. Patent

Skyphos Technologies has been awarded its second U.S. patent, adding to a growing intellectual property portfolio that now includes nearly a dozen patent applications in process around the world. This latest patent secures core technologies and methods that allow micro-scale parts to be produced in seconds, at throughputs designed to exceed legacy manufacturing such as

04/23/2026

CollectiveMinds LLC Places Keith Meadors as Chief Commercial Officer at Genova Diagnostics

CollectiveMinds LLC, a leading executive search firm specializing in life sciences and healthcare, today announced the successful placement of Keith Meadors as Chief Commercial Officer of Genova Diagnostics, a pioneer in advanced diagnostic testing. The appointment marks another milestone for CollectiveMinds in connecting exceptional leadership talent with high-growth organizations across the diagnostics and life sciences

04/22/2026

RIVANNA expands multi-site clinical study for Accuro XV musculoskeletal imaging system

RIVANNA®, developer of AI-enabled clinical decision-support solutions, announced that it has expanded its clinical studies evaluating Accuro® XV, the company’s musculoskeletal imaging system, from two to eight sites nationwide. This expansion follows execution of a funding option by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response